[Vibrio fetus sepsis in thrombophlebitis].
D000074:Acenocoumarol / Q000627:therapeutic use; D000368:Aged; D000372:Agglutination Tests; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000382:microbiology*; D012703:Serotyping; D013924:Thrombophlebitis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000382:microbiology*; D014733:Vibrio / Q000254:growth & development / Q000302:isolation & purification; D014735:Vibrio Infections / Q000188:drug therapy / Q000276:immunology
D000900:Anti-Bacterial Agents; D000906:Antibodies; D000074:Acenocoumarol
Vibrio-fetus-Sepsis bei Thrombophlebits.